Evidence map›Paper›PMID 41929030›Full record

ArticlebioRxiv : the preprint server for biology2026

Germline-somatic residue synergy reshapes antibody encounter-state pathways to enhance HIV-1 recognition.

Sangita Kachhap, Yishak Bililign, Jared Lindenberger, Carrie Saunders, Priyamvada Acharya, Rory Henderson

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sangita KachhapDuke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
Yishak BililignDuke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
Jared LindenbergerDuke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
Carrie SaundersDuke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
Priyamvada AcharyaDuke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
Rory HendersonDuke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.ORCID 0000-0002-4301-6382

Funding

Nonhuman primate studies for development of a prototype HIV vaccine that induces broadly neutralizing antibodiesUM1AI144371 · NIAID · DUKE UNIVERSITY · PI HAYNES, BARTON F. · 2019 to 2025
$190.4M
Project 3 - Dynamics of latent HIV-1 reservoirs: High resolution antigenic mapping and strategies to block reboundU54AI170752 · NIAID · DUKE UNIVERSITY · PI Priyamvada Acharya · 2022 to 2026
$32.0M
Targeting early metastable intermediates of the SARS-CoV-2 spike for vaccine and therapeutics developmentR01AI145687 · NIAID · DUKE UNIVERSITY · PI Priyamvada Acharya · 2019 to 2026
$6.9M
Assessing HIV-1 Broadly Neutralizing Antibody Association Pathways for Vaccine Immunogen DesignDP2AI164323 · NIAID · DUKE UNIVERSITY · PI HENDERSON, RORY · 2021 to 2025
$2.4M
Data commons for 'omic, microscopy and analysis core facilitiesS10OD018164 · OD · DUKE UNIVERSITY · PI WRAY, GREGORY A. · 2014 to 2014
$598k
NIAID NIH HHS DP2 AI164323NIAID NIH HHS R01 AI145687NIAID NIH HHS U54 AI170752NIAID NIH HHS UM1 AI144371NIH HHS S10 OD018164
6 · The paper itself

Abstract

Antibodies initiate antigen recognition through short-lived encounter states. These states are structurally distinct from the bound state and allow an antibody to reach the epitope from diverse approach angles. We previously showed that encounter states enable broadly neutralizing HIV-1 antibodies to access protected epitopes, but how these states evolve during affinity maturation is unknown. Here, we defined encounter-state ensembles for two intermediates in a glycan-dependent antibody clonal lineage using extensive molecular dynamics simulations and Markov state modeling. Somatic mutations in the more mature member did not stabilize the bound state. Instead, they created early glycan-mediated interactions that reoriented the antibody during approach and markedly increased the association rate. This reorientation redistributed productive encounter states across a larger antigen surface. This expanded the antigen surface area over which collisions led to productive binding. The modified encounter state landscape positioned germline residues for conserved contacts and provided a kinetic route that naturally bypasses steric barriers at the epitope. Together, these results show that affinity maturation can proceed by reshaping encounter pathways rather than altering the final complex, revealing a generalizable mechanism by which somatic-germline synergy enhances antigen recognition.

Identifiers

PMID41929030
PMCPMC13041919

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.